Yuqing Cozzens

Yuqing Cozzens, Ph.D. is an analytical scientist with 10 years of biopharmaceutical industry experience spanning biologics, vaccines, and novel therapeutic modalities. She has held scientific roles at Bristol Myers Squibb (BMS), MilliporeSigma, and Pfizer, where she has worked for the past five years. Throughout her career, Dr. Cozzens has supported the development of protein biologics, RNA vaccines, and, more recently, lipidated polypeptides. Her expertise includes analytical method development, qualification, validation, and technology transfer to commercial manufacturing sites, as well as Chemistry, Manufacturing, and Controls (CMC) regulatory support for clinical and commercial programs. She has extensive experience with a wide range of analytical techniques and has contributed to advancing robust methods that support product characterization, process development, and regulatory submissions. Dr. Cozzens earned her Ph.D. in Polymer Science from the University of Massachusetts Lowell. During her doctoral research, she focused on polymer and materials science and published multiple peer-reviewed articles as first author in leading scientific journals, including Macromolecules and Langmuir.